Your browser doesn't support javascript.
Pulmonary fibrosis secondary to COVID-19: a narrative review.
Tanni, Suzana Erico; Fabro, Alexandre Todorovic; de Albuquerque, André; Ferreira, Eloara Vieira Machado; Verrastro, Carlos Gustavo Yuji; Sawamura, Márcio Valente Yamada; Ribeiro, Sergio Marrone; Baldi, Bruno Guedes.
  • Tanni SE; Division of Internal Medicine of Botucatu Medical School, São Paulo State University-UNESP, Botucatu, Brazil.
  • Fabro AT; Department of Pathology and Legal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • de Albuquerque A; Divisão De Pneumologia, Instituto Do Coração (Incor), Hospital Das Clínicas HCFMUSP, Faculdade De Medicina, Universidade De São Paulo, São Paulo, SP, Brazil.
  • Ferreira EVM; Pulmonology Division, Paulista Medical School, Federal University of São Paulo, São Paulo, Brazil.
  • Verrastro CGY; Radiology Division, Paulista Medical School, Federal University of São Paulo, São Paulo, Brazil.
  • Sawamura MVY; Instituto De Radiologia, Hospital Das Clínicas HCFMUSP, Faculdade De Medicina, Universidade De São Paulo, São Paulo, SP, Brazil.
  • Ribeiro SM; Department of Radiology, Botucatu Medical School, São Paulo State University-UNESP, Botucatu, Brazil.
  • Baldi BG; Divisão De Pneumologia, Instituto Do Coração (Incor), Hospital Das Clínicas HCFMUSP, Faculdade De Medicina, Universidade De São Paulo, São Paulo, SP, Brazil.
Expert Rev Respir Med ; 15(6): 791-803, 2021 06.
Artigo em Inglês | MEDLINE | ID: covidwho-1203511
Informação semântica de SemMedBD (por NLM)
1. COVID-19 CAUSES Pulmonary Fibrosis
Sujeito
COVID-19
Predicado
CAUSES
Objeto
Pulmonary Fibrosis
2. Pulmonary Fibrosis PROCESS_OF Patients
Sujeito
Pulmonary Fibrosis
Predicado
PROCESS_OF
Objeto
Patients
3. Lung LOCATION_OF Sequela of disorder
Sujeito
Lung
Predicado
LOCATION_OF
Objeto
Sequela of disorder
4. COVID-19 CAUSES Sequela of disorder
Sujeito
COVID-19
Predicado
CAUSES
Objeto
Sequela of disorder
5. tomography DIAGNOSES Pulmonary Fibrosis
Sujeito
tomography
Predicado
DIAGNOSES
Objeto
Pulmonary Fibrosis
6. pulmonary involvement PROCESS_OF Patients
Sujeito
pulmonary involvement
Predicado
PROCESS_OF
Objeto
Patients
7. COVID-19 PROCESS_OF Patients
Sujeito
COVID-19
Predicado
PROCESS_OF
Objeto
Patients
8. COVID-19 CAUSES Pulmonary Fibrosis
Sujeito
COVID-19
Predicado
CAUSES
Objeto
Pulmonary Fibrosis
9. Pulmonary Fibrosis PROCESS_OF Patients
Sujeito
Pulmonary Fibrosis
Predicado
PROCESS_OF
Objeto
Patients
10. Lung LOCATION_OF Sequela of disorder
Sujeito
Lung
Predicado
LOCATION_OF
Objeto
Sequela of disorder
11. COVID-19 CAUSES Sequela of disorder
Sujeito
COVID-19
Predicado
CAUSES
Objeto
Sequela of disorder
12. tomography DIAGNOSES Pulmonary Fibrosis
Sujeito
tomography
Predicado
DIAGNOSES
Objeto
Pulmonary Fibrosis
13. pulmonary involvement PROCESS_OF Patients
Sujeito
pulmonary involvement
Predicado
PROCESS_OF
Objeto
Patients
14. COVID-19 PROCESS_OF Patients
Sujeito
COVID-19
Predicado
PROCESS_OF
Objeto
Patients
ABSTRACT

Introduction:

Coronavirus disease 2019 (COVID-19) is still increasing worldwide, and as a result, the number of patients with pulmonary fibrosis secondary to COVID-19 will expand over time. Risk factors, histopathological characterization, pathophysiology, prevalence, and management of post-COVID-19 pulmonary fibrosis are poorly understood, and few studies have addressed these issues.Areas coveredThis article reviews the current evidence regarding post-COVID-19 pulmonary fibrosis, with an emphasis on the potential risk factors, histopathology, pathophysiology, functional and tomographic features, and potential therapeutic modalities. A search on the issue was performed in the MEDLINE, Embase, and SciELO databases and the Cochrane library between 1 December 2019, and 25 January 2021. Studies were reviewed and relevant topics were incorporated into this narrative review. Expert opinion Pulmonary sequelae may occur secondary to COVID-19, which needs to be included as a potential etiology in the current differential diagnosis of pulmonary fibrosis. Therefore, serial clinical, tomographic, and functional screening for pulmonary fibrosis is recommended after COVID-19, mainly in patients with pulmonary involvement in the acute phase of the disease. Further studies are necessary to determine the risk factors, markers, pathophysiology, and appropriate management of post-COVID-19 pulmonary fibrosis.
Assuntos
Palavras-chave

Texto completo: Disponível Coleções: Bases de dados internacionais Base de dados: MEDLINE Tipo de documento: Artigo Assunto principal: Fibrose Pulmonar / COVID-19 Tipo de estudo: Estudo diagnóstico / Estudo de etiologia / Fatores de risco Idioma: Inglês Revista: Expert Rev Respir Med Aspecto clínico: Diagnóstico / Etiologia Ano de publicação: 2021

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponível Coleções: Bases de dados internacionais Base de dados: MEDLINE Tipo de documento: Artigo Assunto principal: Fibrose Pulmonar / COVID-19 Tipo de estudo: Estudo diagnóstico / Estudo de etiologia / Fatores de risco Idioma: Inglês Revista: Expert Rev Respir Med Aspecto clínico: Diagnóstico / Etiologia Ano de publicação: 2021
...